Navigation Links
Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt

Geneticist Fred Alt will be awarded the 44th Rosenstiel Award for Distinguished Work in Biomedical Science by Brandeis University for his pioneering research exploring the mechanisms of genomic instability and its implications for the immune system and cancer cells. Alt is the second alumnus to win the Rosenstiel Award; the first, Rod McKinnon, won the Nobel Prize in 2003.

Alt is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School and an investigator at the Howard Hughes Medical Institute at Boston Children's Hospital. He also directs the program in cellular molecular medicine at Children's Hospital Boston.

Sometimes it pays to have genomic rearrangements. In a healthy immune system, antibody genes are purposefully mutated, broken and recombined by programmed mechanisms in order to diversify and strengthen the immune response. But sometimes, this process can go wrong and result in chromosomal abnormalities and cancers such as leukemias and lymphomas.

Alt explores the mechanisms by which particular gene regions are activated for rearrangement and how distant broken DNA segments are joined together, both in healthy immune systems and deadly cancer cells. In four decades in the lab, Alt's research has led the way in expanding understanding of how genomic instability can lead to tumors and lymphomas. His work continues to unveil the complex mechanisms of chromosomal maintenance and the consequences of their inactivation.

"Fred Alt is one of the most inventive and perceptive scientists I know, said James Haber, director of the Rosenstiel Basic Medical Sciences Research Center at Brandeis. "His work has provided a framework on which many others have built to gain a deep understanding of the immune system and the sources of chromosomal translocations and amplifications in cancer."

Established in 1972, the Rosenstiel Award highlights the important role educational institutions play in encouraging and developing basic science. It is presented annually to leading scientists who have made discoveries of particular originality and importance to basic medical research. Many Rosenstiel winners have gone on to win the Lasker and Nobel Prizes.

The Rosenstiel Award for Distinguished Work in Biomedical Science consists of a cash prize and a medal. Alt will officially receive the award in a ceremony April 13, 2015.


Contact: Jarret Bencks
Brandeis University

Related biology news :

1. Brandeis scientists win prestigious prize for circadian rhythms research
2. Karl Deisseroth, Gero Miesenböck and Edward Boyden win Brandeis Gabbay Award in Biotechnology
3. Computer modeling technique goes viral at Brandeis
4. MARC travel awards announced for EB 2012
5. Autism Speaks awards $1.1 million to fund high priority studies
6. NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards
7. SEBM Distinguished Scientist Awards for 2012
8. SEBM Young Investigator Awards for 2012
9. SEBM Best Paper Awards for articles published in 2011
10. March of Dimes awards $250,000 prize to 2 scientists who pioneered advances in skin disorders
11. National Psoriasis Foundation awards more than $2 million for research
Post Your Comments:
(Date:7/17/2019)... ... July 15, 2019 , ... RCH ... Life Sciences and Healthcare companies, announces the availability of new specialty advisory practice, ... direction to start-up and emerging bio-pharma companies interested in achieving specific outcomes related ...
(Date:7/9/2019)... ... July 09, 2019 , ... Murrieta Genomics, a launch pad ... The founder and CEO of Tx Genetic, Helen Harrison, has spent several years ... epithelial connective tissue disorders. , “We are pleased and excited to join the ...
(Date:6/25/2019)... ... , ... ActX has launched a medical genetic interpretation ... can get access to professionally reviewed genetic screening similar to what a physician ... + Ancestry customers., With the ActX + 23andMe service, both 23andMe customers and ...
Breaking Biology News(10 mins):
(Date:7/11/2019)... LAS VEGAS (PRWEB) , ... July 11, 2019 , ... ... 2019, R3 provided complimentary regenerative therapies to eight military Veterans under the R3 Heroes ... procedures being complimentary. , The R3 Heroes Program allow anyone to nominate a military ...
(Date:7/9/2019)... ... July 08, 2019 , ... Balluff has been named a ... the 2019 Innovative Product of the Year which highlights cutting-edge advancements and achievements ... Sensors Expo & Conference 2019, held this week in San Jose, California. ...
(Date:6/26/2019)... ... ... Alice Branton today released research results from preclinical trials on the beneficial impact ... to be beneficial for treating Hypomagnesemia. , The preclinical trial shows:, ... Over 142% increase in particle size , Over 3% alteration ...
(Date:6/18/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived ... for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. The ... This IND is the first of several planned clinical trials which will enable ...
Breaking Biology Technology: